Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Y Ku

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Practical Radiation Oncology|November 3, 2023
The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionStephanie G Worrell, Karyn A Goodman, Nasser K Altorki, et al.
The Annals of Thoracic Surgery|November 3, 2023
The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionStephanie G Worrell, Karyn A Goodman, Nasser K Altorki, et al.
Cancer Immunity|January 8, 2010
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapyJianda Yuan, David B Page, Geoffrey Y Ku, et al.
Annals of Surgery|June 29, 2022
Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort StudyElvira L Vos, Steven B Maron, Robert W Krell, et al.
International Journal of Surgery (London, England)|August 7, 2023
Prognostic value of circumferential radial margin involvement in esophagectomy for esophageal cancer: a case seriesThomas Boerner, Rebecca Carr, Meier Hsu, et al.
Annals of Surgery|July 12, 2023
Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry: A Novel Path for Precision OncologyMiseker Abate, Henry Walch, Kanika Arora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2022
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal AdenocarcinomaSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
The Oncologist|December 2, 2025
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studiesYeon Hee Park, Javier Cortes, Shanu Modi, et al.
Annals of Surgery|August 13, 2021
Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal AdenocarcinomaRebecca A Carr, Meier Hsu, Caitlin A Harrington, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
<sup>18</sup>F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal CancerSamuel L Cytryn, Neeta Pandit-Taskar, Melissa A Lumish, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Practical Radiation Oncology|November 3, 2023
The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionStephanie G Worrell, Karyn A Goodman, Nasser K Altorki, et al.
The Annals of Thoracic Surgery|November 3, 2023
The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionStephanie G Worrell, Karyn A Goodman, Nasser K Altorki, et al.
Cancer Immunity|January 8, 2010
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapyJianda Yuan, David B Page, Geoffrey Y Ku, et al.
Annals of Surgery|June 29, 2022
Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort StudyElvira L Vos, Steven B Maron, Robert W Krell, et al.
International Journal of Surgery (London, England)|August 7, 2023
Prognostic value of circumferential radial margin involvement in esophagectomy for esophageal cancer: a case seriesThomas Boerner, Rebecca Carr, Meier Hsu, et al.
Annals of Surgery|July 12, 2023
Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry: A Novel Path for Precision OncologyMiseker Abate, Henry Walch, Kanika Arora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2022
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal AdenocarcinomaSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
The Oncologist|December 2, 2025
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studiesYeon Hee Park, Javier Cortes, Shanu Modi, et al.
Annals of Surgery|August 13, 2021
Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal AdenocarcinomaRebecca A Carr, Meier Hsu, Caitlin A Harrington, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
<sup>18</sup>F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal CancerSamuel L Cytryn, Neeta Pandit-Taskar, Melissa A Lumish, et al.
Pageof 11